UTHR
$112.86
United Therapeutic
($2.49)
(2.16%)
UTHR
Earnings Whisper ®
$2.77
4th Quarter December 2019
Consensus:  $2.68
Revenue:  $345.48 Mil
Wednesday
Feb 26
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when UTHR reports earnings?
Beat
Meet
Miss

Where is UTHR's stock price going from here?
Up
Flat
Down
Stock chart of UTHR
Analysts
Summary of analysts' recommendations for UTHR
Score
Grade
Pivots
Resistance
$122.89
$119.77
$116.31

$113.19

Support
$109.73
$106.61
$103.15
Tweet
Growth
Description
UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services.
Peers
BioMarin PharmaceuticalRegeneron PharmaceuticalsVertex PharmaceuticalsInterCeptZoetisJohnson & JohnsonMylanUltragenyx PharmaceuticalBristol-Myers SquibbAlkermes